Compare NBTX & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | CCU |
|---|---|---|
| Founded | 2003 | 1850 |
| Country | France | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2018 | 2001 |
| Metric | NBTX | CCU |
|---|---|---|
| Price | $39.35 | $11.78 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 1 | 2 |
| Target Price | ★ $36.00 | $12.00 |
| AVG Volume (30 Days) | ★ 153.6K | 127.7K |
| Earning Date | 03-31-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $58.17 | $7.42 |
| Revenue Next Year | N/A | $4.71 |
| P/E Ratio | ★ N/A | $18.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.41 | $10.71 |
| 52 Week High | $57.14 | $15.36 |
| Indicator | NBTX | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 51.89 |
| Support Level | $36.98 | $11.41 |
| Resistance Level | $41.06 | $12.13 |
| Average True Range (ATR) | 2.95 | 0.37 |
| MACD | -0.29 | -0.06 |
| Stochastic Oscillator | 15.87 | 40.89 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.